VANCOUVER, British Columbia, May 16, 2025 ( GLOBE NEWSWIRE ) -- HI-VIEW RESOURCES INC. ( 'HI-VIEW' OR THE 'COMPANY' ) ( CSE: HVW. OTCQB: HVWRF. FSE: B63 ) announces its intention to consolidate its common shares ( "Shares" ) on a 8-old-for-1-new share basis ( the "Consolidation" ) .

The Filecoin Foundation and Lockheed Martin Space have successfully transmitted data in space using a version of the InterPlanetary File System ( IPFS ) on a satellite orbiting Earth, Marta Belcher, president of the Filecoin Foundation, told Cointelegraph.

Prosecutors said a statement purportedly made by the defendant claimed that the hack of the Securities and Exchange Commission X account "was an inside job." ...

Amphenol APH has outperformed the market over the past 20 years by 10.84% on an annualized basis producing an average annual return of 19.19%. Currently, Amphenol has a market capitalization of $105.36 billion.

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or ...

In the current session, GreenTree Hospitality Gr Inc. GHG is trading at $2.06, after a 0.96% decrease. Over the past month, the stock decreased by 4.69%, and in the past year, by 35.76%. With performance like this, long-term shareholders are more likely to start looking into the company's ...

AerCap Holdings AER has outperformed the market over the past 5 years by 16.97% on an annualized basis producing an average annual return of 32.24%. Currently, AerCap Holdings has a market capitalization of $20.50 billion.

SAN DIEGO, May 16, 2025 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether the board of directors of TaskUs, Inc.

Xylem XYL has outperformed the market over the past 10 years by 2.4% on an annualized basis producing an average annual return of 13.17%. Currently, Xylem has a market capitalization of $31.16 billion.

EMERYVILLE, Calif., May 16, 2025 ( GLOBE NEWSWIRE ) -- 4D Molecular Therapeutics ( Nasdaq: FDMT, 4DMT or the Company ) , a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented ...